World Wires · Story 61301 · unverified · 1 Quelle(n)

Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2

GENEVA--(BUSINESS WIRE)--Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2

Im Desk öffnen

Berichterstattung

• Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2 Finnhub mergers & deals · Stufe D · Clear Net · 2026-10-20 20:35 UTC

Was diese Seite indexiert